Pan-cancer multi-omic ERBB2-HER2 characterization using next-generation sequencing and quantitative proteomics.

Published 03/05/2026

Research record: Pan-cancer multi-omic ERBB2-HER2 characterization using next-generation sequencing and quantitative proteomics.

Published in NPJ Precis Oncol; first publication date 2026-03-05. PMID 41786905.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-03-05

Updated

2026-10-20

Disclaimer

professional use

References